Tyson Foods Q1 earnings beat estimates as chicken demand offsets beef weakness
proactiveinvestors.com
Want to monitor CCCC?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CCCCC4 Therapeutics is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.